{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:33:50Z","timestamp":1781145230313,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.intimp.2021.107936","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T04:51:55Z","timestamp":1626497515000},"page":"107936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Iguratimod decreases bleomycin-induced pulmonary fibrosis in association with inhibition of TNF-\u03b1 in mice"],"prefix":"10.1016","volume":"99","author":[{"given":"Siqi","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziye","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlou","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2021.107936_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12931-019-1022-1","article-title":"The natural history of progressive fibrosing interstitial lung diseases","volume":"20","author":"Kolb","year":"2019","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.intimp.2021.107936_b0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/1744666X.2018.1411190","article-title":"Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review","volume":"14","author":"Atzeni","year":"2018","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.intimp.2021.107936_b0015","doi-asserted-by":"crossref","first-page":"h6819","DOI":"10.1136\/bmj.h6819","article-title":"Management of interstitial lung disease associated with connective tissue disease","volume":"352","author":"Mathai","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2021.107936_b0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41413-019-0067-6","article-title":"Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology","volume":"7","author":"Li","year":"2019","journal-title":"Bone Res."},{"key":"10.1016\/j.intimp.2021.107936_b0025","doi-asserted-by":"crossref","first-page":"107219","DOI":"10.1016\/j.intimp.2020.107219","article-title":"Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-alpha signaling pathways","volume":"90","author":"Li","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2021.107936_b0030","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/1756-185X.13463","article-title":"Iguratimod ameliorates bleomycin-induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase-9","volume":"22","author":"Zhao","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"issue":"10082","key":"10.1016\/j.intimp.2021.107936_b0035","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2021.107936_b0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mam.2018.08.004","article-title":"Developmental pathways in the pathogenesis of lung fibrosis","volume":"65","author":"Chanda","year":"2019","journal-title":"Mol. Aspects Med."},{"issue":"8","key":"10.1016\/j.intimp.2021.107936_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082460","article-title":"TGF-beta Signaling in Lung Health and Disease","volume":"19","author":"Saito","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2021.107936_b0050","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/dvdy.24541","article-title":"Epithelial-mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease","volume":"247","author":"Jolly","year":"2018","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.intimp.2021.107936_b0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-physiol-012110-142225","article-title":"Epithelial-mesenchymal interactions in pulmonary fibrosis","volume":"73","author":"Chapman","year":"2011","journal-title":"Annu. Rev. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107936_b0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000318854","article-title":"Simultaneous stimulation with TGF-beta1 and TNF-alpha induces epithelial mesenchymal transition in bronchial epithelial cells","volume":"155","author":"Kamitani","year":"2011","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107936_b0065","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/ajt.16275","article-title":"PD-1 antibody and ruxolitinib enhances graft-versus-lymphoma effect without increasing acute graft-versus-host disease in mice","volume":"21","author":"Pan","year":"2021","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.intimp.2021.107936_b0070","first-page":"893","article-title":"Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse","volume":"120","author":"Szapiel","year":"1979","journal-title":"Am. Rev. Respir. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2021.107936_b0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","article-title":"Simple method of estimating severity of pulmonary fibrosis on a numerical scale","volume":"41","author":"Ashcroft","year":"1988","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.intimp.2021.107936_b0080","doi-asserted-by":"crossref","first-page":"106597","DOI":"10.1016\/j.intimp.2020.106597","article-title":"Selective inhibition of interleukin-1 receptor-associated kinase 1 ameliorates lipopolysaccharide-induced sepsis in mice","volume":"85","author":"Pan","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107936_b0085","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.mayocp.2018.09.002","article-title":"Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue Diseases","volume":"94","author":"Mira-Avendano","year":"2019","journal-title":"Mayo Clin. Proc."},{"issue":"14","key":"10.1016\/j.intimp.2021.107936_b0090","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s40265-019-01178-x","article-title":"Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD)","volume":"79","author":"Jee","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2021.107936_b0095","doi-asserted-by":"crossref","first-page":"109704","DOI":"10.1016\/j.biopha.2019.109704","article-title":"Molecular mechanisms and clinical application of Iguratimod: A review","volume":"122","author":"Jiang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2021.107936_b0100","article-title":"Interleukin 6 trans-signaling is a critical driver of lung allograft fibrosis","author":"Wheeler","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.intimp.2021.107936_b0105","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2021.107936_b0110","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/jcp.26112","article-title":"TNF-alpha-induced NF-kappaB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis","volume":"233","author":"Hou","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"38","key":"10.1016\/j.intimp.2021.107936_b0115","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1073\/pnas.1507387112","article-title":"TNF-alpha-stimulated fibroblasts secrete lumican to promote fibrocyte differentiation","volume":"112","author":"Pilling","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.intimp.2021.107936_b0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","article-title":"Inflammation and immunity in IPF pathogenesis and treatment","volume":"147","author":"Heukels","year":"2019","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.intimp.2021.107936_b0125","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00281-016-0559-z","article-title":"The IL-1 cytokine family and its role in inflammation and fibrosis in the lung","volume":"38","author":"Borthwick","year":"2016","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107936_b0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1381612033392341","article-title":"Re-evaluation of fibrogenic cytokines in lung fibrosis","volume":"9","author":"Kelly","year":"2003","journal-title":"Curr. Pharm. Des."},{"issue":"36","key":"10.1016\/j.intimp.2021.107936_b0135","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1038\/onc.2011.101","article-title":"Interstitial lung disease induced by gefitinib and toll-like receptor ligands is mediated by Fra-1","volume":"30","author":"Takada","year":"2011","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.intimp.2021.107936_b0140","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.4049\/jimmunol.1900790","article-title":"TNF-alpha and IL-10 Control CXCL13 Expression in Human Macrophages","volume":"204","author":"Bellamri","year":"2020","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2021.107936_b0145","article-title":"Could SCGF-Beta Levels Be Associated with Inflammation Markers and Insulin Resistance in Male Patients Suffering from Obesity-Related NAFLD?","volume":"10","author":"Tarantino","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.intimp.2021.107936_b0150","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.advms.2020.05.006","article-title":"Anti-fibrotic effect of iguratimod on pulmonary fibrosis by inhibiting the fibroblast-to-myofibroblast transition","volume":"65","author":"Lin","year":"2020","journal-title":"Adv. Med. Sci."},{"issue":"Pt 1","key":"10.1016\/j.intimp.2021.107936_b0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1242\/jcs.114.1.131","article-title":"TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP","volume":"114","author":"Han","year":"2001","journal-title":"J. Cell. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2021.107936_b0160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1513\/pats.201203-023AW","article-title":"The impact of TGF-beta on lung fibrosis: from targeting to biomarkers","volume":"9","author":"Fernandez","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"2","key":"10.1016\/j.intimp.2021.107936_b0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/17476348.2021.1829972","article-title":"Recent developments in the pathobiology of lung myofibroblasts","volume":"15","author":"Jiang","year":"2021","journal-title":"Expert. Rev. Respir. Med."},{"issue":"6","key":"10.1016\/j.intimp.2021.107936_b0170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1753465810379801","article-title":"The pathogenesis of idiopathic pulmonary fibrosis","volume":"4","author":"Coward","year":"2010","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2021.107936_b0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/01902140903042589","article-title":"Tumor necrosis factor-alpha enhances both epithelial-mesenchymal transition and cell contraction induced in A549 human alveolar epithelial cells by transforming growth factor-beta1","volume":"36","author":"Yamauchi","year":"2010","journal-title":"Exp. Lung. Res."},{"issue":"1","key":"10.1016\/j.intimp.2021.107936_b0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"Emt: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.intimp.2021.107936_b0185","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ccr.2009.03.016","article-title":"Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion","volume":"15","author":"Wu","year":"2009","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.intimp.2021.107936_b0190","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.onc.1209808","article-title":"NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2","volume":"26","author":"Chua","year":"2007","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.intimp.2021.107936_b0195","first-page":"6873","article-title":"Simultaneous stimulation with tumor necrosis factor-alpha and transforming growth factor-beta1 induces epithelial-mesenchymal transition in colon cancer cells via the NF-kappaB pathway","volume":"15","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.intimp.2021.107936_b0200","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/s41598-018-20390-5","article-title":"Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages\/microglia through an NF-kappaB pathway","volume":"8","author":"Li","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2021.107936_b0205","doi-asserted-by":"crossref","first-page":"4901591","DOI":"10.1155\/2018\/4901591","article-title":"T-614 Promotes Osteoblastic Cell Differentiation by Increasing Dlx5 Expression and Regulating the Activation of p38 and NF-kappaB","volume":"2018","author":"Song","year":"2018","journal-title":"Biomed. Res. Int."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T20:13:18Z","timestamp":1730837598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921005725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":41,"alternative-id":["S1567576921005725"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107936","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iguratimod decreases bleomycin-induced pulmonary fibrosis in association with inhibition of TNF-\u03b1 in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107936"}}